Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Stock Forecast

Stock Price Forecast

The 14 analysts that cover Travere Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $37.21, which forecasts a 13.07% increase in the stock price over the next year. The lowest target is $25 and the highest is $47.

Price Target: $37.21 (+13.07%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$25	$37.21	$35	$47
Change	-24.04%	+13.07%	+6.35%	+42.81%

* Price targets were last updated on Nov 28, 2025.

Analyst Ratings

The average analyst rating for Travere Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	6	6	7	7	7	7
Buy	8	8	7	6	6	6
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	16	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $47	Strong Buy	Reiterates	$47	+42.81%	Nov 28, 2025
Allison Bratzel Piper Sandler	Piper Sandler	Hold Maintains $26 → $35	Hold	Maintains	$26 → $35	+6.35%	Nov 4, 2025
Tyler Van Buren TD Cowen	TD Cowen	Strong Buy Maintains $30 → $40	Strong Buy	Maintains	$30 → $40	+21.54%	Oct 31, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $47	Strong Buy	Reiterates	$47	+42.81%	Sep 19, 2025
Alex Thompson Stifel	Stifel	Hold Maintains $20 → $25	Hold	Maintains	$20 → $25	-24.04%	Sep 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

516.70M

Increased by 121.59%

from 233.18M

Revenue Next Year

705.72M

Increased by 36.58%

from 516.70M

EPS This Year

-0.46

from -4.08

EPS Next Year

0.56

from -0.46

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	198.32M	131.84M	109.46M	145.24M	233.18M	516.70M	705.72M
Revenue Growth	13.11%	-33.52%	-16.97%	32.69%	60.55%	121.59%	36.58%
EPS	-3.56	-3.01	-4.37	-1.50	-4.08	-0.46	0.56
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	59.11
No. Analysts	-	-	-	-	-	17	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	576.9M	842.9M
Avg	516.7M	705.7M
Low	473.6M	568.4M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	147.4%	63.1%
Avg	121.6%	36.6%
Low	103.1%	10.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	0.14	1.81
Avg	-0.46	0.56
Low	-1.04	-0.40

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.